Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Bernina BioInvest

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 12
Average round size
info
The average size of a deal this fund participated in
$9M
Portfolio companies 9
Rounds per year 2.00
Lead investments 2
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.17
Key employees Soon

Areas of investment

  • Biotechnology
  • Biopharma
  • Medical
  • Health Care
  • Pharmaceutical

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Dalbergia Community of Madrid, Madrid, Spain
Grubhub Chicago, Illinois, United States
Luenmei Quantum China, Shanghai
Nextury Ventures Lithuania, Vilniaus Apskritis, Vilnius
RedBird Capital Partners New York, New York, United States
Splash Capital Boulder, Colorado, United States
Tellacq AB -
Tianjin Venture Capital China, Guangdong, Tianjin
Trudell Medical England, London, United Kingdom

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

HAYA Therapeutics

Biopharma
Biotechnology
Health Care
Medical
$5M09 Feb 2022 Lausanne, Vaud, Switzerland

HAYA Therapeutics

Biopharma
Biotechnology
Health Care
Medical
$19M20 May 2021 Lausanne, Vaud, Switzerland

HAYA Therapeutics SA

$18M05 May 2021 -

Synendos Therapeutics

Health Care
Medical
Therapeutics
$21M12 Nov 2020 Basel-Country, Switzerland

Memo Therapeutics

Biotechnology
Collaboration
$15M06 Nov 2020 Zurich, Zurich, Switzerland

ELDICO Scientific

Biopharma
Nanotechnology
$1M07 May 2020 Aargau, Switzerland

ImmunOs Therapeutics

Biotechnology
Drug Discovery
Health Care
Pharmaceutical
$16M10 Dec 2019 Zurich, Switzerland

EraCal

Biotechnology
Pharmaceutical
18 Oct 2019 Zurich, Zurich, Switzerland

Versameb

Biotechnology
Medical
Pharmaceutical
$4M27 Dec 2018 Basel, Basel-Stadt, Switzerland

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Bernina BioInvest?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 12
Average round size 9M
Rounds per year 2.00
Peak activity year 2019
Lead investments 2
Follow on index 0.17
Group Appearance index 0.92

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

HAYA Therapeutics

Biopharma
Biotechnology
Health Care
Medical
$5M09 Feb 2022 Lausanne, Vaud, Switzerland

HAYA Therapeutics

Biopharma
Biotechnology
Health Care
Medical
$19M20 May 2021 Lausanne, Vaud, Switzerland

HAYA Therapeutics SA

$18M05 May 2021 -

Synendos Therapeutics

Health Care
Medical
Therapeutics
$21M12 Nov 2020 Basel-Country, Switzerland

Memo Therapeutics

Biotechnology
Collaboration
$15M06 Nov 2020 Zurich, Zurich, Switzerland

ELDICO Scientific

Biopharma
Nanotechnology
$1M07 May 2020 Aargau, Switzerland

ImmunOs Therapeutics

Biotechnology
Drug Discovery
Health Care
Pharmaceutical
$16M10 Dec 2019 Zurich, Switzerland

EraCal

Biotechnology
Pharmaceutical
18 Oct 2019 Zurich, Zurich, Switzerland

Versameb

Biotechnology
Medical
Pharmaceutical
$4M27 Dec 2018 Basel, Basel-Stadt, Switzerland
Crunchbase icon

Content report

The following text will be sent to our editors: